Por favor, use este identificador para citar o enlazar este ítem:http://uvadoc.uva.es/handle/10324/13854
Título
Macroloides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains
Autor
Año del Documento
2009
Descripción
Producción Científica
Documento Fuente
Journal of Infection Developing Countries 2009; 3(3):159-161.
Zusammenfassung
The current outburst of a new H1N1 swine influenza strain(s) in México and the United States is causing great concern in health authorities and in the general population [1]. With the World Health Organization (WHO) reporting the pandemic potential of the new strain, it is necessary to determine which therapeutic options are available until a specific vaccine is available. Based on information from the Centre for Disease Control (CDC), the virus is sensitive to oseltamivir and zanamivir. Antivirals are strongly affected by viral mutations; thus their efficiency could be lost as the virus changes.
Materias (normalizadas)
Gripe - Vacunas
ISSN
1972-2680
Revisión por pares
SI
DOI
Idioma
eng
Derechos
openAccess
Aparece en las colecciones
Dateien zu dieser Ressource
![Attribution-NonCommercial-NoDerivatives 4.0 International](/themes/Mirage2//images/creativecommons/cc-by-nc-nd.png)